Page last updated: 2024-11-11

bactoprenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6449977
SCHEMBL ID1274179
MeSH IDM0040160

Synonyms (6)

Synonym
12777-41-2
6,10,14,18,22,26,30,34,38,42-tetratetracontadecaen-1-ol, 3,7,11,15,19,23,27,31,35,39,43-undecamethyl- (van)
bactoprenol
(6e,10e,14e,18e,22e,26e,30e,34e,38e)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-6,10,14,18,22,26,30,34,38,42-decaen-1-ol
SCHEMBL1274179
Q409695

Research Excerpts

Overview

Bactoprenol is a critical isoprenoid required for peptidoglycan precursor assembly.

ExcerptReferenceRelevance
"Bactoprenol is a critical isoprenoid required for peptidoglycan precursor assembly."( Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly.
Brockett, M; Liechti, GW; Maurelli, AT; Singh, R; Slade, JA, 2019
)
1.24
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (14.29)18.2507
2000's1 (7.14)29.6817
2010's11 (78.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.38 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index65.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (21.43%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (78.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]